1. Home
  2. PMAX vs DWTX Comparison

PMAX vs DWTX Comparison

Compare PMAX & DWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMAX
  • DWTX
  • Stock Information
  • Founded
  • PMAX 2019
  • DWTX 2012
  • Country
  • PMAX Hong Kong
  • DWTX United States
  • Employees
  • PMAX N/A
  • DWTX N/A
  • Industry
  • PMAX
  • DWTX
  • Sector
  • PMAX
  • DWTX
  • Exchange
  • PMAX Nasdaq
  • DWTX NYSE
  • Market Cap
  • PMAX 6.6M
  • DWTX 5.9M
  • IPO Year
  • PMAX 2024
  • DWTX N/A
  • Fundamental
  • Price
  • PMAX $0.45
  • DWTX $4.05
  • Analyst Decision
  • PMAX
  • DWTX
  • Analyst Count
  • PMAX 0
  • DWTX 0
  • Target Price
  • PMAX N/A
  • DWTX N/A
  • AVG Volume (30 Days)
  • PMAX 820.9K
  • DWTX 3.1M
  • Earning Date
  • PMAX 04-15-2025
  • DWTX 03-31-2025
  • Dividend Yield
  • PMAX N/A
  • DWTX N/A
  • EPS Growth
  • PMAX N/A
  • DWTX N/A
  • EPS
  • PMAX 0.04
  • DWTX N/A
  • Revenue
  • PMAX $5,970,263.00
  • DWTX N/A
  • Revenue This Year
  • PMAX N/A
  • DWTX N/A
  • Revenue Next Year
  • PMAX N/A
  • DWTX N/A
  • P/E Ratio
  • PMAX $8.96
  • DWTX N/A
  • Revenue Growth
  • PMAX 30.05
  • DWTX N/A
  • 52 Week Low
  • PMAX $0.28
  • DWTX $1.62
  • 52 Week High
  • PMAX $4.70
  • DWTX $29.28
  • Technical
  • Relative Strength Index (RSI)
  • PMAX N/A
  • DWTX N/A
  • Support Level
  • PMAX N/A
  • DWTX N/A
  • Resistance Level
  • PMAX N/A
  • DWTX N/A
  • Average True Range (ATR)
  • PMAX 0.00
  • DWTX 0.00
  • MACD
  • PMAX 0.00
  • DWTX 0.00
  • Stochastic Oscillator
  • PMAX 0.00
  • DWTX 0.00

About PMAX Powell Max Limited Class A Ordinary Shares

Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. Key revenue is derived from Hong Kong.

About DWTX DOGWOOD THERAPEUTICS INC

Dogwood Therapeutics Inc formerly Virios Therapeutics Inc is a development-stage biotechnology company. It is focused advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia (FM) and Long-COVID (LC). Its product candidates includes IMC-1 and IMC-2, IMC-1, is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.

Share on Social Networks: